A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma
GRIFFIN 研究最终分析的简明语言摘要,该研究评估了达雷妥尤单抗联合来那度胺、硼替佐米和地塞米松治疗新诊断多发性骨髓瘤患者的疗效。
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2024.2408909
Voorhees, Peter M; Sborov, Douglas W; Laubach, Jacob; Kaufman, Jonathan L; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D Jr; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Efebera, Yvonne A; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Dinner, Shira; Gries, Katharine S; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Usmani, Saad Z; Richardson, Paul G